Caricamento...
Convalescent plasma to treat coronavirus disease 2019 (COVID‐19): considerations for clinical trial design
Case series studying convalescent plasma use in the treatment of COVID‐19 have been promising, but additional, high‐quality studies are needed to determine the efficacy of the treatment when applied for prophylaxis, for early phases of illness, and for severe illness. Previous studies of convalescen...
Salvato in:
| Pubblicato in: | Transfusion |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley & Sons, Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267607/ https://ncbi.nlm.nih.gov/pubmed/32374891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15843 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|